Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective

[Background] To assess the cost-effectiveness of using next-generation sequencing (NGS) compared to sequential single-testing (SST) for molecular diagnostic and treatment of patients with advanced non-small cell lung cancer (NSCLC) from a Spanish single-center perspective, the Hospital Universitario...

Descripción completa

Detalles Bibliográficos
Autores: Álava, Enrique de, Pareja, María Jesús, Carcedo, David, Arrabal, Natalia, García, José Francisco, Bernabé Caro, Reyes
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/305165
Acceso en línea:http://hdl.handle.net/10261/305165
https://api.elsevier.com/content/abstract/scopus_id/85131084830
Access Level:acceso abierto
Palabra clave:Non-small cell lung cancer (NSCLC)
Cost-effectiveness
Molecular profiling
Next-generation sequencing
Oncogenic drivers
Sequential single testing
Descripción
Sumario:[Background] To assess the cost-effectiveness of using next-generation sequencing (NGS) compared to sequential single-testing (SST) for molecular diagnostic and treatment of patients with advanced non-small cell lung cancer (NSCLC) from a Spanish single-center perspective, the Hospital Universitario Virgen del Rocio (HUVR).

Similares en LA Referencia